Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic & Medicinal …, 2023 - Elsevier
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic & …, 2023 - pubmed.ncbi.nlm.nih.gov
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic & …, 2022 - europepmc.org
Graphical abstract COVID-19 is an ongoing worldwide pandemic. Even today, there is a
need for the development of effective therapeutic agents. SARS-CoV-2 is known as the …
need for the development of effective therapeutic agents. SARS-CoV-2 is known as the …
[HTML][HTML] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic & …, 2023 - ncbi.nlm.nih.gov
ABSTRACT COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for
the development of effective therapeutic agents. SARS-CoV-2 is known as the causative …
the development of effective therapeutic agents. SARS-CoV-2 is known as the causative …
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic and …, 2023 - keio.elsevierpure.com
抄録 COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
[引用][C] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
大江知之 - Bioorg Med Chem Lett., 2023 - cir.nii.ac.jp
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[引用][C] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic & Medicinal …, 2023 - cir.nii.ac.jp
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
D Katagishi, D Yasuda, K Takahashi… - Bioorganic and …, 2023 - keio.elsevierpure.com
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease.
D Katagishi, D Yasuda, K Takahashi… - Bioorganic & …, 2022 - europepmc.org
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …
development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of …